Fantofarone

This classification denotes an enzyme inhibitor and calcium channel blocker with the molecular formula C31H38N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KU213XYO69, chemically known as 3,4-dimethoxy-n-methyl-n-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)benzeneethanmine but generally known as fantofarone, which bears US NIH Compound Identifier 119349. European Medicines Agency schedules Fantofarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07510MIG. The term FANTOFARONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). FANTOFARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fantofarone under HS 29339990 and SITC 51577. As of Q4 2014, FANTOFARONE remains the US FDA Preferred Term for this commodity. Fantofarone bears US NLM identifiers UMLS ID C0245720 and NCI Concept Code C73029. SMILES: S(=O)(=O)(C1C(C(C)C)CN2C1CCCC2)C1CCC(OCCCN(CCC2CC(OC)C(OC)CC2)C)CC1.